Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms
Myxomas comprise the majority of cardiac tumors . Patients may experience signs of cardiac obstruction or systemic embolism, accompanied by non-specific systemic symptoms such as fever or malaise . Embolization to the central nervous system is common. However, while embolic stroke due to cardiac myxoma is treated by tumor resection, delayed neurological complications may arise from metastatic spread of myxomatous cells into the brain, causing either aneurysms or solid tumor growth. In these rare cases, the clinical course is often complicated and an effective therapeutic regimen has not yet been established (Online Resource 1) [3, 4, 5, 6, 7, 8, 9, 10].
KeywordsBody Surface Area Cardiac Myxoma Hematoma Volume Solid Tumor Growth Severe Neurological Impairment
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
This study has been approved by the appropriate ethics committee and has therefore been performed in the accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.